Sign in
4

Changes in Ownership

GeneDx Holdings Corp. Filed Acc 0001689575-26-000013

CHIEF EXECUTIVE OFFICER acquired 3,404 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stueland Katherine CHIEF EXECUTIVE OFFICER 2026-03-06 Grant or award +3,404 $88.11 $299,926 42,087 D
Loading xslF345X05/form4-03092026_110351.xml…